>> 全站文章索引 >> 第9页:
Symptom presentation and classroom functioning in a nonclinical sample of children with social phobia - [Bernstein GA, Bernat DH, Davis AA, Layne AE.]
Effects of acute treatment with paroxetine,citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow:a microdialysis study in Swiss mice1 - [D J P David, M Bourin, G Jego, C Przybylski, P Jolliet, A M Gardier]
The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: Assessment of its Evaluative Properties Over the Course of a - [Sarah J. Brooks, Stan Kutcher]
Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring - [H. Dix Christensen, William F. Rayburn and Christina L. Gonzalez]
Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro - [C. Lass-Florl, M. P. Dierich, D. Fuchs, E. Semenitz, I. Jenewein, M. Ledochowski]
Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression - [Madhukar H Trivedi1 MD, A John Rush1 MD, Roseanne Armitage1 Ph.D, Christina M Gullion1 Ph.D, Bruce D Grannemann1 MA, Paul J Orsulak1 Ph.D and Howard P Roffwarg2 MD]
Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring - [Zhuo Chen, Kate Waimey, Louis D. Van de Kar, Gonzalo A. Carrasco, Michelle Landry and George Battaglia]
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder - [V. K. Yeragani, R. B. Pohl, V. C. Jampala, R. Balon, C. Ramesh and K. Srinivasan 472.]
Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder - [Vikram K. Yeragani, M.B.B.S. 1 2 3 *, Robert Pohl, M.D. 1, V.C. Jampala, M.B.B.S. 2, Richard Balon, M.D. 1, C. Ramesh, M.D. 1, K. Srinivasan, M.D. 4 AD:1Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan2Veterans Affair]
Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells - [Gunter Kenis, Harry Steinbusch, Marc De Baets and Michael Maes]
D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder - [Bruce R. Lawford, , Ross McD. Young, Ernest P. Noble, Burnett Kann, Leanne Arnold, John Rowell and Terry L. Ritchie]
Post-Stroke Depression Relationships to Functional Impairment, Coping Strategies, and Rehabilitation Outcome. - [Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H.]
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity - [E. J. Bull, P. H. Hutson and K. C. F. Fone]
Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity - [Eleanor J. Bull, Peter H. Hutson and Kevin C. F. Fone]
Screening for Depression in Stroke Patients: The Reliability and Validity of the Center for Epidemiologic Studies Depression Scale - [SHINAR, D. AVID; GROSS, C. YNTHIA; PRICE, T. HOMAS; BANKO, M. ARYANN; BOLDUC, P. AULA; ROBINSON, R. OBERT]
Course of depression in patients with comorbid anxiety disorders - [Sherbourne CD, Wells KB.]
The effects of cognitive behavior therapy on depression in older patients with cardiovascular risks - [Strachowski D, Khaylis A, Conrad A, Neri E, Spiegel D, Taylor CB.]
Coping with rheumatoid arthritis pain in daily life- Within-person analyses reveal hidden vulnerability for the formerly depressed - [Conner TS, Tennen H, Zautra AJ, Affleck G, Armeli S, Fifield J]
A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults - [Randall D. Marshall, M.D. *, Roberto Lewis-Fernandez, M.D., Carlos Blanco, M.D., Ph.D., H. Blair Simpson, M.D., Ph.D., Shu-Hsing Lin, Ph.D., Donna Vermes, M.S.N.P.P., Wendy Garcia, B.A., Franklin Schneier, M.D., Yuval Neria, Ph.D., Arturo Sanchez-Lacay, M]
Effects of olanzapine on aggressiveness in heroin dependent patients - [G. Gerra, G. Di Petta, A. D'Amore, P. Iannotta, F. Bardicchia, F. Falorni, A. Coacci, G. Strepparola, G. Campione, A. Lucchini, et al.]
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents - [Mauricette Brocco, Anne Dekeyne, Sylvie Veiga, Sylvie Girardon and Mark J. Millan]
Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study - [Karl Rickels, Rocco Zaninelli, James McCafferty, Kevin Bellew, et al]
Neuropharmacology of 5-hydroxytryptamine - [A Richard Green1]
Focus on paroxetine. - [Green B]
MOOD, ANXIETY, AND PHYSICAL ILLNESS - [Balon R.]
Post-Stroke Depression in Primary Support Persons: Predicting Those at Risk - [Tompkins, Connie A.; Schulz, Richard; Rau, Marie T.]
Status of minor depression or dysthymia in primary care following a randomized controlled treatment - [Thomas E. Oxman, James E. Barrett, Anjana Sengupta, Wayne Katon, John W. Williams, Ellen Frank and Mark Hegel]
Steroid-Free Immunosuppression in Kidney Transplant Recipients and Prograf Monotherapy - [B?ckman L, Aselius H, Lindberger K, Svensson L, Str?mbom U, Olausson E, Hadimeri H, Deurell SI, Norrby J, G?bel M, Ebermark A, Olausson M.]
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. - [Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M]
A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial - [Linmarie Sikich1, Robert M Hamer1,2, Robert A Bashford1, Brian B Sheitman1,3 and Jeffrey A Lieberman1,4]
Detrimental Antidepressant Drug–Drug Interactions: Are They Clinically Relevant? - [Sheldon Preskorn1 and Steve Werder1]
Depressive personality disorder, dysthymia, and their relationship to perfectionism - [Huprich SK, Porcerelli J, Keaschuk R, Binienda J, Engle B.]
Depressive personality disorder, dysthymia, and their relationship to perfectionismsup?-sup - [Huprich SK, Porcerelli J, Keaschuk R, Binienda J, Engle B.]
Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts - [Lankupalle D Jayanthi, Gricelly Vargas, Louis J DeFelice]
Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography - [E. Lacassie, J. -M. Gaulier, P. Marquet, J. -F. Rabatel and G. Lachatre]
Vagus Nerve Stimulation (VNS?) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome - [Harold A Sackeim1,2,3 Ph.D, A John Rush5 MD, Mark S George7,8,10 MD, Lauren B Marangell11 MD, Mustafa M Husain5 MD, Ziad Nahas7 MD, Christopher R Johnson11 MD, Stuart Seidman1,2 MD, Cole Giller6 MD, Stephen Haines9 MD, Richard K Simpson Jr12 MD and Robert]
Mirtazapine Orally Disintegrating Tablet Versus Sertraline:A Prospective Onset of Action Study - [Behnke K, S?gaard J, Martin S, B?uml J, Ravindran AV, Agren H, Vester-Blokland ED.]
Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach - [H. Kirchherr and W.N. Kühn-Velten]
Training to recognise the early signs of recurrence in schizophrenia - [R Morriss, CA Bolton, MAMIR Faizal, M Marshall, JP McCarthy]
Mirtazapine versus other anti-depressive agents for depression - [N Watanabe, C Barbui, R Churchill, A Cipriani, TA Furukawa, McGuire HF and Omori I for the Meta-Analysis of New Generation Antidepressants (MANGA) Study Group]
The experience of bipolar disorder: a personal perspective on the impact of mood disorder symptoms - [J Licinio1]
Depression after cardiac transplant treated with interpersonal psychotherapy and paroxetine - [Mark Miller]
Posttraumatic stress disorder: A state-of-the-science review - [Charles B. Nemeroff, J. Douglas Bremner, Edna B. Foa, Helen S. Mayberg, Carol S. North and Murray B. Stein]
Paroxetine during lactation: is it really safe for the infant - [TW de Vries, LTW de Jong-van de Berg, M Hadders-Algra]
Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients - [Fouzia Laghrissi-Thode, Bruce G Pollock, Mark C Miller, Benoit H Mulsant, et al.]
Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior - [Deanna M Sasaki-Adams BS and Ann E Kelley Ph.D]
Evidence-based guidelines for the pharmacological treatment of anxiety disorders-recommendations from the British association for psychopharmacology - [Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU; British Association for Psychopharmacology.]
Antidepressants for the Treatment of Neuropathic Pain - [William E Cayley JR]
Interpersonal problems and emotional intelligence in compulsive hoarding - [Grisham JR, Steketee G, Frost RO.]
Affective disorders, antidepressant drugs and brain metabolism - [A Moretti, A Gorini and R F Villa]
Neurogenesis and depression-what animal models tell us about the link - [Vollmayr B, Mahlstedt MM, Henn FA.]
Effect of antidepressant drugs on 6-OHDA-treated mice in the FST - [F. Chenu, E. Dailly and M. Bourin]
Antidepressant Treatment and Dehydroepiandrosterone Sulfate: Different Effects of Amitriptyline and Paroxetine - [Michael Deuschle, Peter Luppa, Maria Gilles, Bettina Hamann, Isabella Heuser]
Sex differences in clinical response to olanzapine compared with haloperidol - [Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M, Crawford A, Tollefson G.]
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. - [Mogg K, Baldwin DS, Brodrick P, Bradley BP]
Alterations in platelet serotonin transporter binding in women with postpartum onset major depression - [D. Jeffrey Newport, Michael J. Owens, David L. Knight, Kim Ragan, Neal Morgan, Charles B. Nemeroff and Zachary N. Stowe]
Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene - [P Courtet1, P Baud2, M Abbar3, J P Boulenger4, D Castelnau1, D Mouthon2, A Malafosse2 and C Buresi2]
Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide - [B Bondy1, A Erfurth1, S de Jonge1, M Krüger1 and H Meyer2]
Bupropion (Zyban, sustained-release tablets): reported adverse reactions - [Hebert, Sylvie]
Major advances in bipolar disorder - [Mitchell PB, Malhi GS, Ball JR.]
Impaired platelet [(3)H]paroxetine binding in female patients with borderline personality disorder. - [Ng Ying Kin NM, Paris J, Schwartz G, Zweig-Frank H, Steiger H, Nair NP]
Diagnosis and management of depression in primary care: A clinical update and review - [Dr. R.A. Remick, Department of Psychiatry, St. Paul]
The effect of alexithymic features on response to antidepressant medication in patients with major depression - [Aytekin ?zsahin, M.D., ?zcan Uzun, M.D. *, Adnan Cansever, M.D., Zeynep Gulcat, Ph.D. AD:Department of Psychiatry, Gulhane School of Medicine, Ankara, Turkey]
Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring - [Christine Frahnert, Marie Luise Rao and Katja Grasm?der]
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain - [Agnès Besson, Nasser Haddjeri, Pierre Blier and Claude de Montigny]
Inclusion of the Antidepressant Paroxetine in β-cyclodextrin - [Mino R. Caira, Elise De Vries, Luigi R. Nassimbeni, Victor W. Jacewicz]
MONITORING THE SAFETY OF LICENSED MEDICINES - [Alasdair Breckenridge, Kent Woods & June Raine about the authors]
From Galactorrhea to Osteopenia: Rethinking Serotonin-Prolactin Interactions - [Ana B F Emiliano1,2 and Julie L Fudge1,3]
Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine - [J. Rodríguez Flores, J.J. Berzas Nevado, A.M. Contento Salcedo and M.P. Cabello Díaz]
Atypical antipsychotics in bipolar depression-Neurobiological basis and clinical implications - [Brugue E, Vieta E]
Paroxetine (Paxil, Seroxat): Increased risk of suicide in pediatric patients - [Eric Wooltorton]
FDA Advisory on Antidepressants - [Carrie Morantz, Brian Torrey]
PHARMACOKINETIC VARIABILITY OF ANTICANCER AGENTS - [Samir D. Undevia, Gonzalo Gomez-Abuin & Mark J. Ratain about the author]
Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive-Compulsive and Panic Disorders - [Pierre Blier MD, Ph.D and Claude de Montigny MD, Ph.D]
Social, Psychological, and Psychiatric Interventions Following Terrorist Attacks: Recommendations for Practice and Research - [Edna B Foa1, Shawn P Cahill1, Joseph A Boscarino2, Stevan E Hobfoll3,4, Mooli Lahad5,6, Richard J McNally7 and Zahava Solomon8]
Tail-suspension induced hyperthermia: a new measure of stress reactivity - [Xiaoqing Liu, Dorothy Peprah and Howard K. Gershenfeld]
An open trial of paroxetine for the offensive subtype of taijin kyofusho and social anxiety disorder - [Toshihiko Nagata, M.D., Ph.D. 1 *, Irene van Vliet, M.D. 2, Hisashi Yamada, M.D. 1, Kouhei Kataoka, M.D. 1, Toshiya Iketani, M.D., Ph.D. 1, Nobuo Kiriike, M.D., Ph.D. 1 1Department of Neuropsychiatry, Osaka City University Medical School, Osaka, Japan2Dep]
Application of the chiral base desymmetrisation of imides to the synthesis of the alkaloid jamtine and the antidepressant paroxetine - [Christopher D. Gill, Daniel A. Greenhalgh and Nigel S. Simpkins]
Overview of antidepressants currently used to treat anxiety disorder - [Feighner JP.]
Neurotransmitter transporters and their impact on the development of psychopharmacology - [Leslie Iversen1]
A call for the creation of personalized medicine databases - [David Gurwitz1, Jeantine E. Lunshof2 and Russ B. Altman3 About the authors]
Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats - [Andrew Harkin, Thomas J. Connor, Jane Mulrooney, John P. Kelly and Brian E. Leonard]
Cognitive Behavior Therapy and Paroxetine in the Treatment of Hypochondriasis: A Randomized Controlled Trial - [Anja Greeven, Anton J L M van Balkom, Sako Visser, Jille W Merkelbach, et al. The American Journal of Psychiatry. Washington:]
Genital sympathetic skin responses in fibromyalgia syndrome - [Unlü E, Ula? UH, Gür?ay E, Tuncay R, Berber S, Cak?i A, Odaba?i Z.]
Depression and its relation to lesion location after stroke - [MacHale, Siobhan M.; O, Rourke Suzanne; Wardlaw, Joanna M.; Dennis, Martin S.]
The spermicidal and antitrichomonas activities of SSRI antidepressants - [V.S. Kiran Kumar S.T., Vishnu Lal Sharma, Pratibha Tiwari, Divya Singh, Jagdamba Prasad Maikhuri, Gopal Gupta and Man Mohan Singh]
Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. - [Gilmor ML, Owens MJ, Nemeroff CB]
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product - [Scott P. Runyon, Jason P. Burgess, Philip Abraham, Kathryn I. Keverline-Frantz, Judy Flippen-Anderson, Jeffrey Deschamps, Anita H. Lewin, Hernán A. Navarro, John W. Boja, Michael J. Kuhar, et al.]
Validation of a Depression Screening Measure for Stroke Inpatients - [Rybarczyk, Bruce Ph; Winemiller, David R.; Lazarus, Lawrence W.; Haut, Allyson Ph; Hartman, Carolyn M.]
Depressing research - [Anonymous]
Immunomodulators as an antimicrobial tool - [Pirofski LA, Casadevall A.]
A novel serotonin transporter ligand: (5-Iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol - [Zhi-Ping Zhuang, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton and Hank F. Kung]
High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions - [Per Plenge and Ove Wiborg]
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders - [Y W-Y Yu1, S-J Tsai2,3, T-J Chen4, C-H Lin4 and C-J Hong2,3]
Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain - [Pilar Rosel 1, Belén Arranz 2, Miguel Oros 1, Julio Vallejo 3, Luis San 2, Jan Marcusson 4, Miguel A. Navarro 1 AD:1Hormone Unit, Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain2Benito Menni, Mental Health Care Institute, Barcelona, Spain]
PLATELET SEROTONERGIC BINDING SITES IN ALCOHOL-DEPENDENT PATIENTS - [Belen Arranz, Pilar Rosel, Salvador Sarro, Encarna Zaldivar, Ramon Cano, Miguel Angel Navarro, Luis San]
Serotonin Receptor and Transporter Ligands - Current Status - [S. Oh, H-J. Ha, D. Chi, H. Lee]
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice - [F.O. Goeldner, G. Pigatto, A.F. Ribeiro, H.B. Machado and R. Boerngen-Lacerda]
Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder - [D. Joel, J. Doljansky, N. Roz and M. Rehavi]
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers - [Liston HL, DeVane CL, Boulton DW, Risch SC, Markowitz JS, Goldman J.]
分页: 1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |